PD-L1 Expression and Lymphocytic Response in Neoadjuvant-Treated Breast Cancers

被引：0
|
作者：
Schatz-Siemers, Nina
Harrison, Beth
Formenti, Silvia C.
Demaria, Sandra
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
275
引用
收藏
页码：70A / 71A
页数：2
相关论文
共 50 条
  • [21] PD-L1 protein expression in breast cancer
    Saastad, Sigurd A.
    Skjervold, Anette H.
    Ytterhus, Borgny
    Engstrom, Monica Jernberg
    Bofin, Anna M.
    JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (11) : 730 - 736
  • [22] PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies
    E. S. Stovgaard
    M. Bokharaey
    K. List-Jensen
    A. Roslind
    I. Kümler
    E. Høgdall
    D. Nielsen
    E. Balslev
    Breast Cancer Research and Treatment, 2020, 181 : 553 - 560
  • [23] PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies
    Stovgaard, E. S.
    Bokharaey, M.
    List-Jensen, K.
    Roslind, A.
    Kumler, I
    Hogdall, E.
    Nielsen, D.
    Balslev, E.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 553 - 560
  • [24] The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
    Michael T. Barrett
    Elizabeth Lenkiewicz
    Smriti Malasi
    Anamika Basu
    Jennifer Holmes Yearley
    Lakshmanan Annamalai
    Ann E. McCullough
    Heidi E. Kosiorek
    Pooja Narang
    Melissa A. Wilson Sayres
    Meixuan Chen
    Karen S. Anderson
    Barbara A. Pockaj
    Breast Cancer Research, 20
  • [25] The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
    Barrett, Michael T.
    Lenkiewicz, Elizabeth
    Malasi, Smriti
    Basu, Anamika
    Yearley, Jennifer Holmes
    Annamalai, Lakshmanan
    McCullough, Ann E.
    Kosiorek, Heidi E.
    Narang, Pooja
    Sayres, Melissa A. Wilson
    Chen, Meixuan
    Anderson, Karen S.
    Pockaj, Barbara A.
    BREAST CANCER RESEARCH, 2018, 20
  • [26] PD-L1 and MHC Class I Expression in Ovarian Cancers Treated with Checkpoint Inhibitor Therapy
    Griesinger, Laurie
    Nyarko-Odoom, Akua
    Martinez, Santos Acosta
    Shen, Nancy
    Ring, Kari
    Gaughan, Elizabeth
    Mills, Anne
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 751 - 752
  • [27] PD-L1 and MHC Class I Expression in Ovarian Cancers Treated with Checkpoint Inhibitor Therapy
    Griesinger, Laurie
    Nyarko-Odoom, Akua
    Martinez, Santos Acosta
    Shen, Nancy
    Ring, Kari
    Gaughan, Elizabeth
    Mills, Anne
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 751 - 752
  • [28] Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
    Magbanua, M. J. M.
    Swigart, L. B.
    Wu, H-T
    Hirst, G. L.
    Yau, C.
    Wolf, D. M.
    Tin, A.
    Salari, R.
    Shchegrova, S.
    Pawar, H.
    Delson, A. L.
    DeMichele, A.
    Liu, M. C.
    Chien, A. J.
    Tripathy, D.
    Asare, S.
    Lin, C-H J.
    Billings, P.
    Aleshin, A.
    Sethi, H.
    Louie, M.
    Zimmermann, B.
    Esserman, L. J.
    Veer, L. J. van 't
    ANNALS OF ONCOLOGY, 2021, 32 (02) : 229 - 239
  • [29] PD-L1 expression in microsatellite-unstable colorectal cancers
    Zhang, Li
    LABORATORY INVESTIGATION, 2019, 99
  • [30] CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
    Gao, Feng
    Chen, Jing
    Wang, Jia
    Li, Peixiang
    Wu, Sheng
    Wang, Jue
    Ji, Yong
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2019, 20
12345